Director
DIN: 03608266
Nandkishore Jiwanrao Duragkar is currently associated with 2 companies in various capacities such as Director and Individual Promoter. They serve as a Director at NVAS BIOCHEM PRIVATE LIMITED and have other roles in different companies. They are registered with the Ministry of Corporate Affairs (MCA) of India and hold a DIN of 03608266.Nandkishore Jiwanrao Duragkar is currently involved in 2 different roles. Their most recent position is with VISHWAROOP LIFE SCIENCES PRIVATE LIMITED as a Director. The first company Nandkishore Jiwanrao Duragkar was appointed to as a director was NVAS BIOCHEM PRIVATE LIMITED. Nandkishore Jiwanrao Duragkar is not disqualified by the Registrar of Companies under Section 164(2), and their DIN has not been deactivated due to failure to file the DIR-3 KYC Form.
Nandkishore Jiwanrao Duragkar is currently associated with 2 companies in various capacities such as Director and Individual Promoter. They serve as a Director at NVAS BIOCHEM PRIVATE LIMITED and have other roles in different companies. They are registered with the Ministry of Corporate Affairs (MCA) of India and hold a DIN of 03608266.Nandkishore Jiwanrao Duragkar is currently involved in 2 different roles. Their most recent position is with VISHWAROOP LIFE SCIENCES PRIVATE LIMITED as a Director. The first company Nandkishore Jiwanrao Duragkar was appointed to as a director was NVAS BIOCHEM PRIVATE LIMITED. Nandkishore Jiwanrao Duragkar is not disqualified by the Registrar of Companies under Section 164(2), and their DIN has not been deactivated due to failure to file the DIR-3 KYC Form.
3
Male
India
Call +91 81049 46419 and we'll pull the verified contact details for you.
Current Companies (2)
Current LLPs (0)
Past Companies (0)
3 Years 1y 6m Interval
| Company Name | Designation | Date of Appointment |
|---|---|---|
| NVAS BIOCHEM PRIVATE LIMITED | Director | 13-Sep-2011 |
| VISHWAROOP LIFE SCIENCES PRIVATE LIMITED | Director | 17-Feb-2022 |
| VISHWAROOP LIFE SCIENCES PRIVATE LIMITED | Individual Promoter | 17-Feb-2022 |